Brain Health Imaging Institute (BHII)

BHII Director


“Gloria

Gloria Chiang, M.D., Vice Chair, Clinical and Translational Research, Associate Professor of Clinical Radiology, and BHII Director, is a board-certified radiologist specializing in neuroradiology. Dr. Chiang, a graduate of Harvard Medical School, completed her residency and fellowship at the University of California San Francisco Medical Center and is currently the principal investigator on two NIH R01 grants that combine innovative, quantitative MR and PET-imaging techniques with fluid biomarkers to elucidate Alzheimer’s disease pathogenesis. Dr. Chiang also serves as co-chair of the NIH Clinical Neuroscience and Neurodegeneration Study Section, senior editor of the American Journal of Neuroradiology, and on the executive committee of the American Society of Functional Neuroradiology.

BHII Founding Co-Director


Mony J. de Leon

Mony J. de Leon, Ed.D., is founding co-director the of the Brain Health Imaging Institute. Trained in gerontology and neuroscience, his research focuses on the clinical detection of brain changes underlying cognitive dysfunction, and the characterization of mechanisms contributing to misfolded brain proteins and tissue damage in aging and Alzheimer’s disease (AD). His team’s post-mortem validated biomarker discoveries of hippocampal atrophy and brain glucose metabolism deficits predicting clinical outcomes have contributed to the current standard diagnostic assessment of AD.



BHII Mission

The Brain Health Imaging Institute (BHII) of the Weil Cornell Medicine (WCM) Department of Radiology was founded in 2019. BHII is a neurodegeneration research-dedicated organization focused on improving understanding of the contributions of aging, gender, and genetics to neurodegenerative processes, and developing treatments for Alzheimer’s disease (AD).

BHII Scientific Objectives

BHII research objectives include development and use of advanced medical imaging and biomarker technology to improve the early and specific diagnosis and mechanistic treatment of brain neurodegenerative diseases. This includes diseases marked by AD spectrum pathology (senile amyloid plaque, neurofibrillary tangle, Lewy body, and TDP43) as well as brain impairments due to environmental and biological exposures. The latter include: traumatic brain injury (TBI), COVID-19, sleep apnea, hypertension, oral bacterial dysbiosis, lipid metabolism disorders, fatty liver disease, and genetics.

BHII investigators have developed procedures for examining: blood flow and oxygen and glucose metabolism; plasma, cerebrospinal fluid (CSF), and brain concentrations of AD-related proteins; functional magnetic resonance imaging (fMRI) under activation and resting states; brain inflammation, age-related changes in permeability of brain blood vessels to water, and radiotracers to examine clearance of metabolic waste from brain CSF.

Currently, the major biological emphasis is on small vessel biology, the inflammasome, bacterial dysbiosis, and brain energetics. In a nutshell, the BHII is organized around four basic themes: 1) biological characterization and treatment of memory and dementing disorders, 2) development of target research populations for biomarker assessment (Alzheimer’s disease, vascular disease, pediatric epilepsy, traumatic brain injury, aging), 3) applying novel imaging to enhance understanding of neurodegenerative disease, 4) tissue-based characterization of diagnostic and mechanistic biomarkers.

BHII Core Activities

BHII operations encompass four major cores. 1) The Clinical Core is responsible for recruiting, assessing, and monitoring research participants. 2) The Imaging Core has developed a standardized research grade MR image acquisition, and manages the storage, and data processing for all projects. It provides guidance for specialized image acquisition projects. 3) The Biomarker Core manages collection, processing, storage and distribution of biofluids and tissues. In January 2022, the Lipidomics and Biomarker Lab under the direction of Laura Beth McIntire opened in the BHII in the Feil Building. 4) The Data Core manages the relational database, data entry, and statistical analyses.

BHII Laboratories

Ten core Principal Investigator (PI)-led laboratories form the heart of the BHII membership. Seven more PI-led laboratories are closely affiliated with the BHII. All 17 of these fully operational and funded labs come from radiology, neurology, or both, and are engaged in aging and dementia imaging research.

Core BHII Laboratories

Gloria Chiang, M.D., Vice Chair, Clinical and Translational Research, Associate Professor of Radiology, and BHII Director
Mony J. de Leon, Ed.D., Professor of Neuroscience in Radiology and BHII Founding Co-Director
Tracy Butler, M.D., Associate Professor of Neurology in Radiology
Lidia Glodzik, M.D., Ph.D., Associate Professor of Neuroscience in Radiology
Ray Razlighi, Ph.D., Associate Professor of Radiology
Sudhin Shah, Ph.D., Assistant Professor of Radiology
Silky Pahlajani, M.D.,  Assistant Professor of Neuropsychiatry Research in Radiology
Amy Kuceyeski, Ph.D., Associate Professor Department of Radiology
Yi Li, M.D., Associate Professor of Radiology
Sumit Niogi, Ph.D., Assistant Professor of Radiology
Laura Beth McIntire, Ph.D., Assistant Professor of Pharmacology in Radiology

Affiliated BHII Laboratories

Ajay Gupta, M.D., Vice Chair of Radiology and Professor of Radiology
Jana Ivanidze, M.D., Assistant Professor of Radiology
James Kelly, Ph.D., Assistant Professor of Radiology
Ilhami Kovanlikaya, MD Associate Professor of Radiology
Anna Nordvig, M.D., Assistant Professor of Neurology
Neal Parikh, M.D., Assistant Professor of Neurology